The 34th International Austrian Winter Symposium took place from the 22nd to the 25th of January 2020 in picturesque Zell am See, Austria. The symposium was organized by the Austrian Society of Nuclear Medicine & Molecular Imaging (OGNMB) and was held under the auspices of our this year’s Congress President Ora Israel from Haifa, Israel. […]
The LBI Applied Diagnostics was part of a collaboration together with the Division of Nuclear Medicine at the Medical University of Vienna and the Christian Doppler Labor for Applied Metabolomics at the annual meeting of the SNMMI in Anaheim, California in 2019. In preperation for the congress, the team of WebsEdge who are partnering with SNMMI visited […]
Johannes Längle, Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik für Chirurgie, belegte zusammen mit WissenschafterInnen des Comprehensive Cancer Center (CCC) der MedUni Wien und des AKH Wien, dass Histon-Deazetylase-Inhibitoren (HDACi) in Kombination mit dem Wirkstoff Trastuzumab die körpereigene Immunabwehr in Form der Phagozytose („Auffressen“) von Brustkrebszellen positiv verstärken. Die Studie wurde unter anderem im Rahmen des […]
We are very proud to announce that Loan Tran, PhD student of the program line Molecular Pathology, was awarded a DOC grant by the Austrian Academy of Sciences (ÖAW) to fund the continuation of her PhD project’s research on colorectal cancer.
The MIC Festival of the Medical Imaging Cluster (MIC) of the Medical University of Vienna took place last week on June, 6th 2019. This year’s motto was Digital Revolution in Medical Imaging, highlighting the ever growing importance of big data, digitalization and computational analysis and their translation to clinical routine and research. Just as last […]
In a joint research effort supported by the Swiss National Science Foundation, the groups of Prof. Gilles Gasser (Chimie ParisTech) and Prof. Thomas Mindt (LBIAD) have developed a new chelator for the radiolabelling of antibodies and other molecules with the PET radiometal zirconium-89.[1] The new chelator, termed DFO*, provides 89Zr-complexes that are extraordinarily stable in […]
A bit over one year after meeting with our Scientific Advisory Board (SAB) for the first time, our LBI:AD had their second meeting with the SAB last week on the 13th of May 2019. The SAB consists of five internationally renowned experts, which were again invited to review our institute’s research, to evaluate our progress […]
Thomas Dillinger, PhD student of our LBI’s Program Line Molecular Pathology, has spent two months with Boehringer Ingelheim in Vienna to gain insights into the research-driven pharmaceutical industry, to pick up on new laboratory techniques and to establish fruitful connections with new colleagues from various fields of expertise. His stay was funded thanks to a […]
By Loan Tran, PhD student, PL Molecular Pathology, Egger group Internship (05.02.18-30.03.18) at Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan Founded in 1858, Keio is one of the most prestigious private universities in Japan. Exactly one year ago, I had the honor to join the laboratory of Assoc. Prof. Yoshimasa Saito and […]
Congratulations to Dr. med. univ. Johannes Längle to the Researcher of the Month Award! Fitting to this month’s Colorectal Cancer Awareness Campaign, the award was bestowed by the Medical University of Vienna on occasion of his recent publication about colorectal liver metastases and the implication of DNA damage with their prognosis and treatment response. The […]
